Transgenomic wave nucleic acid fragment analysis system preventative and corrective maintenance services

Ended Purchase Order Awarded Last action

Contract number
HHSF223201400063A
Awardee
Awarding agency
Obligated
$28,650

Award facts

Contract value 100% obligated
$28,650.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Omaha, NE 68164, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Novation Agreement 4 $0
Other Administrative Action 3 $0
Exercise an Option 2 $9,550
Exercise an Option 1 $9,550
Original award $9,550

About this award

This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Ads Biotec Inc., a small business contractor, for the preventative and corrective maintenance services of a TransGenomic WAVE Nucleic Acid Fragment Analysis System. The contract has a ceiling value of $28,650.00 and an ultimate completion date of July 22, 2017. This contract award was set aside for total small business participation.

Quick answers

Who was awarded contract HHSF223201400063A?

HHSF223201400063A was awarded to Ads Biotec Inc. by Food and Drug Administration (Department of Health and Human Services) on April 2, 2014.

How much is contract HHSF223201400063A worth?

The government has obligated $28,650 on HHSF223201400063A.

Was contract HHSF223201400063A competed?

The extent of competition for HHSF223201400063A was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award